These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
905 related articles for article (PubMed ID: 16596224)
1. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928 [TBL] [Abstract][Full Text] [Related]
3. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]. Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963 [TBL] [Abstract][Full Text] [Related]
4. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
5. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
6. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148 [TBL] [Abstract][Full Text] [Related]
7. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
8. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Gure AO; Chua R; Williamson B; Gonen M; Ferrera CA; Gnjatic S; Ritter G; Simpson AJ; Chen YT; Old LJ; Altorki NK Clin Cancer Res; 2005 Nov; 11(22):8055-62. PubMed ID: 16299236 [TBL] [Abstract][Full Text] [Related]
10. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159 [TBL] [Abstract][Full Text] [Related]
11. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA; Neel HB; Strome SE; Roche P Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237 [TBL] [Abstract][Full Text] [Related]
12. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423 [TBL] [Abstract][Full Text] [Related]
13. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819 [TBL] [Abstract][Full Text] [Related]
14. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
15. NY-ESO-1 may be a potential target for lung cancer immunotherapy. Lee L; Wang RF; Wang X; Mixon A; Johnson BE; Rosenberg SA; Schrump DS Cancer J Sci Am; 1999; 5(1):20-5. PubMed ID: 10188057 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer. Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764 [TBL] [Abstract][Full Text] [Related]
17. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer. Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959 [TBL] [Abstract][Full Text] [Related]
18. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517 [TBL] [Abstract][Full Text] [Related]
19. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Söling A; Schurr P; Berthold F Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332 [TBL] [Abstract][Full Text] [Related]
20. Expression of melanoma-antigen-A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancer. Dango S; Wang XT; Gold M; Cucuruz B; Klein CA; Passlick B; Sienel W Lung Cancer; 2010 Mar; 67(3):290-5. PubMed ID: 19467731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]